We are analyzing https://link.springer.com/article/10.1007/s11906-013-0416-6.

Title:
AT2 Receptor and Tissue Injury: Therapeutic Implications | Current Hypertension Reports
Description:
The renin-angiotensin system (RAS) plays an important role in the initiation and progression of tissue injuries in the cardiovascular and nervous systems. The detrimental actions of the AT1 receptor (AT1R) in hypertension and vascular injury, myocardial infarction and brain ischemia are well established. In the past twenty years, protective actions of the RAS, not only in the cardiovascular, but also in the nervous system, have been demonstrated. The so-called protective arm of the RAS includes AT2-receptors and Mas receptors (AT2R and MasR) and is characterized by effects different from and often opposing those of the AT1R. These include anti-inflammation, anti-fibrosis, anti-apoptosis and neuroregeneration that can counterbalance pathological processes and enable recovery from disease. The recent development of novel, small-molecule AT2R agonists offers a therapeutic potential in humans with a variety of clinical indications.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

atr, pubmed, google, scholar, cas, angiotensin, receptor, stimulation, type, cardiac, injury, protein, cells, expression, activation, hypertension, receptors, neuronal, atrmediated, unger, kinase, vascular, effects, mice, pathways, role, central, reduced, increased, apoptosis, antiinflammatory, effect, tissue, actions, signaling, neurite, cell, mechanisms, steckelings, brain, outgrowth, neuroprotection, cardiovascular, ang, inhibition, study, rats, therapeutic, demonstrated, disease,

Topics {✒️}

nω-nitro-l-arginine-methyl ester-induced hypertension spinal cord injury c-jun n-terminal kinase aortic root aneurysm integrated view renin–angiotensin–aldosterone system afford long-term cardioprotection sébastien foulquier renin-angiotensin-aldosterone syst mitogen-activated protein kinase aortic aneurysm at2r-mediated anti-fibrosis appears renin-angiotensin system renin-angiotensin-system at2 receptor-interacting protein angiotensin at2 receptor–implications afford tissue/organ protection angiotensin ii-mediated apoptosis mitogen-activated protein kinases at2 receptor-mediated apoptosis n-methyl-d-aspartate at2r-mediated anti-atherogenic actions direct at2-receptor stimulation at2r-mediated tissue protection peptide at2-receptor agonists at2r-mediated anti-inflammatory actions experimental myocardial infarction ras includes at2-receptors angiotensin ii stimulates mitogen-activated protein angiotensin ii receptors central nervous system transcription factor nf-kappab moderate cardio-selective overexpression at2 receptor-independent mechanism apolipoprotein e-deficient mice at2r-mediated anti-inflammation angiotensin at2 receptor stroke-induced superoxide production ulrike muscha steckelings brain-derived neurotrophic factor modulates t-cell differentiation author information authors anti-inflammatory actions induced apolipoprotein e-null mice moderate cardiac-selective overexpression nerve growth factor anti-inflammatory pattern tetracyclin-regulated system ang ii-mediated effect

Questions {❓}

Angiotensin II type 2 receptor agonists–where should they be applied?
Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?
How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:AT2 Receptor and Tissue Injury: Therapeutic Implications
         description:The renin-angiotensin system (RAS) plays an important role in the initiation and progression of tissue injuries in the cardiovascular and nervous systems. The detrimental actions of the AT1 receptor (AT1R) in hypertension and vascular injury, myocardial infarction and brain ischemia are well established. In the past twenty years, protective actions of the RAS, not only in the cardiovascular, but also in the nervous system, have been demonstrated. The so-called protective arm of the RAS includes AT2-receptors and Mas receptors (AT2R and MasR) and is characterized by effects different from and often opposing those of the AT1R. These include anti-inflammation, anti-fibrosis, anti-apoptosis and neuroregeneration that can counterbalance pathological processes and enable recovery from disease. The recent development of novel, small-molecule AT2R agonists offers a therapeutic potential in humans with a variety of clinical indications.
         datePublished:2014-01-11T00:00:00Z
         dateModified:2014-01-11T00:00:00Z
         pageStart:1
         pageEnd:10
         sameAs:https://doi.org/10.1007/s11906-013-0416-6
         keywords:
            Renin-angiotensin system
            AT2 receptor
            Angiotensin II
            CGP42112
            PD123319
            Signaling
            Tissue injury
            Inflammation
            Fibrosis
            Apoptosis
            Growth promotion/inhibition
            Cardioprotection
            Vascular protection
            Neuroprotection
            Neuroregeneration
            Myocardial infarction
            Aortic aneurysm
            Atherosclerosis
            Hypertension
            Stroke
            Spinal cord injury
            Internal Medicine
            Cardiology
            Metabolic Diseases
            Nephrology
            Primary Care Medicine
            General Practice / Family Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11906-013-0416-6/MediaObjects/11906_2013_416_Fig1_HTML.gif
         isPartOf:
            name:Current Hypertension Reports
            issn:
               1534-3111
               1522-6417
            volumeNumber:16
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Pawel Namsolleck
               affiliation:
                     name:Maastricht University
                     address:
                        name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chiara Recarti
               affiliation:
                     name:Maastricht University
                     address:
                        name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sébastien Foulquier
               affiliation:
                     name:Maastricht University
                     address:
                        name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ulrike Muscha Steckelings
               affiliation:
                     name:University of Southern Denmark
                     address:
                        name:Institute of Molecular Medicine, Department of Cardiovascular and Renal Physiology, University of Southern Denmark, Odense, Denmark
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thomas Unger
               affiliation:
                     name:Maastricht University
                     address:
                        name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:AT2 Receptor and Tissue Injury: Therapeutic Implications
      description:The renin-angiotensin system (RAS) plays an important role in the initiation and progression of tissue injuries in the cardiovascular and nervous systems. The detrimental actions of the AT1 receptor (AT1R) in hypertension and vascular injury, myocardial infarction and brain ischemia are well established. In the past twenty years, protective actions of the RAS, not only in the cardiovascular, but also in the nervous system, have been demonstrated. The so-called protective arm of the RAS includes AT2-receptors and Mas receptors (AT2R and MasR) and is characterized by effects different from and often opposing those of the AT1R. These include anti-inflammation, anti-fibrosis, anti-apoptosis and neuroregeneration that can counterbalance pathological processes and enable recovery from disease. The recent development of novel, small-molecule AT2R agonists offers a therapeutic potential in humans with a variety of clinical indications.
      datePublished:2014-01-11T00:00:00Z
      dateModified:2014-01-11T00:00:00Z
      pageStart:1
      pageEnd:10
      sameAs:https://doi.org/10.1007/s11906-013-0416-6
      keywords:
         Renin-angiotensin system
         AT2 receptor
         Angiotensin II
         CGP42112
         PD123319
         Signaling
         Tissue injury
         Inflammation
         Fibrosis
         Apoptosis
         Growth promotion/inhibition
         Cardioprotection
         Vascular protection
         Neuroprotection
         Neuroregeneration
         Myocardial infarction
         Aortic aneurysm
         Atherosclerosis
         Hypertension
         Stroke
         Spinal cord injury
         Internal Medicine
         Cardiology
         Metabolic Diseases
         Nephrology
         Primary Care Medicine
         General Practice / Family Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11906-013-0416-6/MediaObjects/11906_2013_416_Fig1_HTML.gif
      isPartOf:
         name:Current Hypertension Reports
         issn:
            1534-3111
            1522-6417
         volumeNumber:16
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Pawel Namsolleck
            affiliation:
                  name:Maastricht University
                  address:
                     name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chiara Recarti
            affiliation:
                  name:Maastricht University
                  address:
                     name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sébastien Foulquier
            affiliation:
                  name:Maastricht University
                  address:
                     name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ulrike Muscha Steckelings
            affiliation:
                  name:University of Southern Denmark
                  address:
                     name:Institute of Molecular Medicine, Department of Cardiovascular and Renal Physiology, University of Southern Denmark, Odense, Denmark
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thomas Unger
            affiliation:
                  name:Maastricht University
                  address:
                     name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Current Hypertension Reports
      issn:
         1534-3111
         1522-6417
      volumeNumber:16
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Maastricht University
      address:
         name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
         type:PostalAddress
      name:Maastricht University
      address:
         name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
         type:PostalAddress
      name:Maastricht University
      address:
         name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
         type:PostalAddress
      name:University of Southern Denmark
      address:
         name:Institute of Molecular Medicine, Department of Cardiovascular and Renal Physiology, University of Southern Denmark, Odense, Denmark
         type:PostalAddress
      name:Maastricht University
      address:
         name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Pawel Namsolleck
      affiliation:
            name:Maastricht University
            address:
               name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
               type:PostalAddress
            type:Organization
      name:Chiara Recarti
      affiliation:
            name:Maastricht University
            address:
               name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
               type:PostalAddress
            type:Organization
      name:Sébastien Foulquier
      affiliation:
            name:Maastricht University
            address:
               name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
               type:PostalAddress
            type:Organization
      name:Ulrike Muscha Steckelings
      affiliation:
            name:University of Southern Denmark
            address:
               name:Institute of Molecular Medicine, Department of Cardiovascular and Renal Physiology, University of Southern Denmark, Odense, Denmark
               type:PostalAddress
            type:Organization
      name:Thomas Unger
      affiliation:
            name:Maastricht University
            address:
               name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
      name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
      name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
      name:Institute of Molecular Medicine, Department of Cardiovascular and Renal Physiology, University of Southern Denmark, Odense, Denmark
      name:CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands

External Links {🔗}(220)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.91s.

LINK . SPRINGER . COM {}